Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 08, 2023

SELL
$25.86 - $46.71 $25,316 - $45,729
-979 Reduced 1.8%
53,286 $2.48 Million
Q1 2023

May 11, 2023

BUY
$26.05 - $32.31 $69,683 - $86,429
2,675 Added 5.19%
54,265 $1.56 Million
Q4 2022

Feb 14, 2023

BUY
$19.77 - $42.23 $179,887 - $384,250
9,099 Added 21.41%
51,590 $1.61 Million
Q3 2022

Nov 10, 2022

BUY
$14.97 - $22.65 $36,960 - $55,922
2,469 Added 6.17%
42,491 $862,000
Q2 2022

Aug 11, 2022

BUY
$13.19 - $22.1 $335,448 - $562,047
25,432 Added 174.31%
40,022 $621,000
Q1 2022

May 12, 2022

BUY
$14.54 - $25.02 $61,911 - $106,535
4,258 Added 41.21%
14,590 $279,000
Q4 2021

Feb 10, 2022

BUY
$22.41 - $37.54 $231,540 - $387,863
10,332 New
10,332 $262,000

Others Institutions Holding DICE

About DICE Therapeutics, Inc.


  • Ticker DICE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,430,000
  • Description
  • DICE Therapeutics, Inc., a biopharmaceutical company, builds various oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. Its platform DELSCAPE, is designed to discover selective oral small molecules to modulate protein-protein interactions (PPIs) as effectively as systemic biologics. The company's lea...
More about DICE
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.